Brief: Kane Biotech Reports Q3 Loss Per Share Of $0.01
16/11/2021 21:16
Nov 16 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS
* KANE BIOTECH INC - QTRLY BASIC AND DILUTED LOSS PER SHARE
$0.01
Source text for Eikon: ID:nGNXb7H5dP
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update